Register | Login or

General Information

Websitebbbiotechventures...
Employees

Funds

Offices

Tags

BB Biotech Ventures

BB BIOTECH VENTURES is a healthcare-dedicated venture capital fund, focused on companies that develop and market drugs and medical devices. The Guernsey–based fund is advised by the Bellevue Asset Management Group, which has operations in Curaçao, Boston/USA and Kusnacht/Zurich, Switzerland.

BB BIOTECH VENTURES has a dedicated team of investment advisors and an advisory board. In addition, it is supported by all of the Group’s health care investment experts, and an extensive network of specialists and advisors. Our goal is to maximize the returns to our investors. To achieve this goal, we combine hard working, experience, networking, and focus on value creation.

Milestones

Investments

Company Date Round Size Participants
Radius Health 2/12Series C$21.4M7
Probiodrug 1/12Unattributed€15M6
AM-Pharma 9/11Series D€29.2M4
Radius Health 7/11Series C$66M7
Atlas Genetics 7/11Series B£16.9M5
Tioga Pharmaceuticals 2/10Series C$18M4
Molecular Partners 12/09Series B$44.2M5
Probiodrug 11/09Series B$54M8
Palyon Medical 5/09Series A$21M5
Orthocon 4/09Series B$25M3
Aerovance 4/09Unattributed$38M8
Radius Health 11/08Series C$15M6
BioVascular 2/08Series C$10.9M3
Molecular Partners 8/07Series A$15.6M4
Radius Health 4/07Series B$57.5M6

Videos

Sources

  1. Radius Health, Inc.: Series C $21.4M (onbiovc.com) [edit]
  2. Probiodrug Raises €15M in Funding (finsmes.com) [edit]
  3. AM-Pharma Raises €29.2m in Series D Financing (am-pharma.com) [edit]
  4. Radius Health, Inc.: Series C $66M (onbiovc.com) [edit]
  5. Atlas Genetics Ltd Completes £16.9 million Series B Financing led by Novartis Venture Funds (atlasgenetics.com) [edit]
  6. Tioga Pharmaceuticals, Inc.: Series C $18M (onbiovc.com) [edit]
  7. Swiss Protein Therapy Co. Molecular Partners Pulls In $44M Series B (fis.dowjones.com) [edit]
  8. Probiodrug Closes Series B Financing Round exceeding EUR 36 Million (US$54 Million) (probiodrug.de) [edit]
  9. Palyon Medical Corp.: Series A $21M (onbiovc.com) [edit]
  10. Orthocon Raises $25 Million (pehub.com) [edit]
  11. Aerovance inhales $38M for asthma drugs (venturebeat.com) [edit]
  12. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million (radiuspharm.mwnewsroom.com) [edit]
  13. BioVascular Inc. Closes $10.87 Million Series C Financing (salesandmarketingnetwork.com) [edit]
  14. MOLECULAR PARTNERS SECURES $15.56 million IN SERIES A FINANCING (molecularpartners.com) [edit]
  15. Radius Raises $57.5 Million in Second Private Financing Round (radiuspharm.com) [edit]
Edit This Page
Last Edited 2/13/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy